Colgate-Palmolive (NYSE:CL) insider Jennifer Daniels sold 7,375 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $73.18, for a total transaction of $539,702.50. Following the sale, the insider now directly owns 38,691 shares in the company, valued at approximately $2,831,407.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Colgate-Palmolive (NYSE:CL) traded down $0.11 during trading hours on Friday, reaching $73.24. 1,873,600 shares of the company were exchanged, compared to its average volume of 3,599,905. Colgate-Palmolive has a 1 year low of $63.43 and a 1 year high of $77.27. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. The stock has a market cap of $65,020.00, a price-to-earnings ratio of 25.56, a price-to-earnings-growth ratio of 3.36 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same period last year, the firm posted $0.73 EPS. Colgate-Palmolive’s quarterly revenue was up 2.8% on a year-over-year basis. equities research analysts anticipate that Colgate-Palmolive will post 2.88 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 15th. Investors of record on Monday, October 23rd were given a $0.40 dividend. The ex-dividend date was Friday, October 20th. This represents a $1.60 dividend on an annualized basis and a yield of 2.18%. Colgate-Palmolive’s dividend payout ratio (DPR) is 61.78%.

A number of equities analysts have recently commented on CL shares. Jefferies Group reaffirmed a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a report on Thursday, September 28th. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Macquarie started coverage on shares of Colgate-Palmolive in a report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 target price on the stock. Royal Bank of Canada reaffirmed a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a report on Sunday, October 8th. Finally, KeyCorp reaffirmed a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Two research analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $76.04.

A number of large investors have recently bought and sold shares of CL. Jacobi Capital Management LLC boosted its position in shares of Colgate-Palmolive by 125.5% during the 3rd quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after purchasing an additional 803 shares in the last quarter. OLD Second National Bank of Aurora purchased a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $109,000. Krilogy Financial LLC boosted its position in shares of Colgate-Palmolive by 23.0% during the 2nd quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock worth $115,000 after purchasing an additional 289 shares in the last quarter. Harbour Capital Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the 1st quarter worth $121,000. Finally, Hanson & Doremus Investment Management boosted its position in shares of Colgate-Palmolive by 4.5% during the 2nd quarter. Hanson & Doremus Investment Management now owns 1,630 shares of the company’s stock worth $121,000 after purchasing an additional 70 shares in the last quarter. Hedge funds and other institutional investors own 72.96% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Colgate-Palmolive (CL) Insider Sells $539,702.50 in Stock” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and international copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/12/15/colgate-palmolive-cl-insider-sells-539702-50-in-stock.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.